Literature DB >> 11182636

Identification of monoclonal insulin autoantibodies in insulin autoimmune syndrome associated with HLA-DRB1*0401.

M Murakami1, M Mizuide, K Kashima, A Kojima, S I Tomioka, T Kohama, O Araki, T Ogiwara, H Mizuma, M Mori.   

Abstract

We have characterized HLA and insulin autoantibodies in a Japanese female patient with insulin autoimmune syndrome. Serological HLA typing demonstrated the patient had HLA-DR4, and DNA typing showed she had HLA-DRB1*0401 which has not been reported in patients with insulin autoimmune syndrome in Japan. A single binding affinity of insulin autoantibodies was demonstrated by Scatchard analysis and immunoglobulin class of insulin autoantibodies was exclusively IgG-kappa. HLA-DRB1*0406 is strikingly associated with patients with insulin autoimmune syndrome who have polyclonal insulin autoantibodies. The present report demonstrated the first Japanese patient with insulin autoimmune syndrome carrying HLA-DRB1*0401 who was revealed to have monoclonal insulin autoantibodies. The present results indicate that HLA molecules are the major determinants of polyclonal insulin autoantibodies and monoclonal insulin autoantibodies in insulin autoimmune syndrome. Copyright 2001 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11182636     DOI: 10.1159/000063437

Source DB:  PubMed          Journal:  Horm Res        ISSN: 0301-0163


  2 in total

1.  HLA-DRB1 alleles are associated with the susceptibility to sporadic Parkinson's disease in Chinese Han population.

Authors:  Congcong Sun; Lei Wei; Feifei Luo; Yi Li; Jiaobiao Li; Feiqi Zhu; Ping Kang; Rensi Xu; Lulu Xiao; Zhuolin Liu; Pingyi Xu
Journal:  PLoS One       Date:  2012-11-06       Impact factor: 3.240

2.  Hypoglycemic coma due to insulin autoimmune syndrome induced by methimazole: A rare case report.

Authors:  Yiyi Zhang; Tieyun Zhao
Journal:  Exp Ther Med       Date:  2014-09-15       Impact factor: 2.447

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.